Self-microemulsion composition of insoluble medicine

A technology for insoluble drugs and compositions, which can be used in pharmaceutical formulations, emulsion delivery, and medical preparations of non-active ingredients. It can solve problems such as interference in drug determination, greater influence of oil phase particle size, and easy oxidation. , to achieve the effects of improving bioavailability, fast dissolution rate in vitro, and promoting dissolution and dissolution

Active Publication Date: 2013-01-02
NORTH CHINA PHARMA COMPANY
View PDF12 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] It is worth noting that the above-mentioned self-microemulsion preparations all add an oil phase, which makes the existing self-microemulsion preparations have the following disadvantages: 1) the oil has a relatively large influence on the particle size of the self-microemulsion, and it has a great influence on the determination of some drugs. There is interference; 2) many oil phases (such as castor oil, olive oil, corn oil, etc.) are easily oxidized or irritating, which makes the selection of oil phases limited; , high humidity and airtightness requirements; 4) liquid oil phase, surfactants, etc. can easily dissolve the components in the capsule shell (such as gelatin, pigments, light-proofing agents and other additives), resulting in increased impurities
[0007] Therefore, existing self-microemulsion preparations have many problems that are difficult to solve from the perspective of prescription, and the development of new self-microemulsion preparations without oil phase is a problem that needs to be solved by those skilled in the art.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Self-microemulsion composition of insoluble medicine
  • Self-microemulsion composition of insoluble medicine
  • Self-microemulsion composition of insoluble medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1 The prescription and preparation method of tacrolimus self-microemulsion composition

[0028] Element

[0029] The drug is dissolved in propylene carbonate, then propylene glycol is added, and finally Cremophor RH 40 is added, and magnetic or mechanical stirring is performed to obtain a tacrolimus self-microemulsion composition.

Embodiment 2

[0030] Embodiment 2 The prescription and preparation method of tacrolimus self-microemulsion composition

[0031] Element

[0032] The drug is dissolved in diethylene glycol monoethyl ether, citric acid is added, and finally Labrasol is added, and magnetic or mechanical stirring is performed to obtain the tacrolimus self-microemulsion composition.

Embodiment 3

[0033] The prescription and preparation method of embodiment 3 sirolimus self-microemulsion compositions

[0034] Element

[0035] Dissolving the drug in diethylene glycol monoethyl ether, then adding Cremophor EL 35, stirring magnetically or mechanically to obtain the sirolimus self-microemulsion composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a self-microemulsion composition of an insoluble medicine and without an oil phase. The composition comprises active medicines, a solvent and a surfactant, and can be adsorbed by a solid adsorbent to further obtain a solid self-microemulsion composition. The high in-vitro dissolution rate and the high in-vivo biological utilization degree of the self-microemulsion composition disclosed in the invention are maintained.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular to a self-microemulsion composition of poorly soluble drugs. Background technique [0002] Based on the classification system of biopharmaceuticals, APIs can be divided into four categories according to their differences in solubility and permeability. Drugs with low solubility and high permeability belong to class II of the biopharmaceutical classification, and the rate-limiting step of absorption is the low dissolution rate of the drug. Dosage form plays a decisive role in the absorption of this type of drug in the gastrointestinal tract. Traditional tablets are difficult to improve the bioavailability of this type of drug. Appropriate dosage form is the key to the successful development of this type of drug product. (Lv Yifan et al., Research on the Administration Strategy of Insoluble Drugs, World Clinical Drugs, 2009, 30(1): 41-45) [0003] Microemulsion (Micro Emul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/107A61K47/18A61K47/22A61K47/24A61K47/26A61K47/32A61K47/34A61K47/36A61K47/38
Inventor 王会娟张莉周立明范彦令
Owner NORTH CHINA PHARMA COMPANY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products